Alimera “Paladin” M-01-15-004

Completed Studies

A phase 4 safety study of IOP Signals in patients treated with Iluvien (Fluocinolone Acetonide Intravitreal Implant) 0.19 MG

Duration: 36 Months

This entry was posted in Uncategorized. Bookmark the permalink.